The Current Ratio as of September 2024 (TTM) for Can-Fite BioPharma Ltd. (CANF) is 4.90

According to Can-Fite BioPharma Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 4.90. This represents a change of 5.94% compared to the average of 4.63 of the last 4 quarters.

Can-Fite BioPharma Ltd. (CANF) Historical Current Ratio (quarterly & annually)

How has CANF Current Ratio performed in the past?

The mean historical Current Ratio of Can-Fite BioPharma Ltd. over the last ten years is 5.26. The current 4.90 Current Ratio has changed 9.22% with respect to the historical average. Over the past ten years (40 quarters), CANF's Current Ratio was at its highest in in the September 2015 quarter at 10.51. The Current Ratio was at its lowest in in the December 2019 quarter at 2.18.

Can-Fite BioPharma Ltd. (CANF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Can-Fite BioPharma Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Can-Fite BioPharma Ltd. (CANF) Average Current Ratio

How has CANF Current Ratio performed in the past?

The current Current Ratio of Can-Fite BioPharma Ltd. (CANF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Can-Fite BioPharma Ltd. (CANF) Current Ratio vs. Peers

How is CANF’s Current Ratio compared to its peers?

Can-Fite BioPharma Ltd.’s Current Ratio is greater than ImmuCell Corporation (2.37), greater than Compugen Ltd. (4.12), greater than Evogene Ltd. (4.37), less than CollPlant Biotechnologies Ltd. (6.27), greater than Protalix BioTherapeutics, Inc. (1.33), greater than Corvus Pharmaceuticals, Inc. (3.62), greater than Aldeyra Therapeutics, Inc. (4.41), greater than Gamida Cell Ltd. (0.35), greater than Checkpoint Therapeutics, Inc. (0.26), greater than Candel Therapeutics, Inc. (1.62), greater than BioRestorative Therapies, Inc. (2.82), less than XTL Biopharmaceuticals Ltd. (11.43), greater than Cingulate Inc. (1.20), less than Adial Pharmaceuticals, Inc. (5.69), greater than TransCode Therapeutics, Inc. (1.25), greater than Aditxt, Inc. (0.07), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than Avenue Therapeutics, Inc. (4.30), greater than BiondVax Pharmaceuticals Ltd. (4.12), greater than Oramed Pharmaceuticals Inc. (2.25), greater than MediWound Ltd. (1.65), greater than BioLineRx Ltd. (1.61),

Build a custom stock screener for Can-Fite BioPharma Ltd. (CANF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Can-Fite BioPharma Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Can-Fite BioPharma Ltd. (CANF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Can-Fite BioPharma Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.